{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:34:00Z","timestamp":1789497240505,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/jcp.0b013e3182905ffb","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T09:53:48Z","timestamp":1371203628000},"page":"479-484","source":"Crossref","is-referenced-by-count":63,"title":["A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control Subjects"],"prefix":"10.1097","volume":"33","author":[{"given":"James L.","family":"Roerig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine J.","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1381\/096089203765887598","article-title":"Overweight and obesity worldwide now estimated to involve 1.7 billion people.","volume":"13","author":"Deitel","year":"2003","journal-title":"Obes Surg"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008.","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.289.2.187","article-title":"Years of life lost due to obesity.","volume":"289","author":"Fontaine","year":"2003","journal-title":"JAMA"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/j.1550-8528.1998.tb00322.x","article-title":"Current estimates of the economic cost of obesity in the United States.","volume":"6","author":"Wolf","year":"1998","journal-title":"Obes Res"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans.","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js980173a","article-title":"Pharmacokinetic considerations in obesity.","volume":"88","author":"Blouin","year":"1999","journal-title":"J Pharm Sci"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.mn.7800206","article-title":"Impairment of hepatic microcirculation in fatty liver.","volume":"10","author":"Ijaz","year":"2003","journal-title":"Microcirculation"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/clpt.1994.150","article-title":"Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.","volume":"56","author":"OShea","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/j.1326-5377.2005.tb07061.x","article-title":"Obesity, weight loss and bariatric surgery.","volume":"183","author":"OBrien","year":"2005","journal-title":"Med J Aust"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11695-009-9960-1","article-title":"Prompt reduction in use of medications for comorbid conditions after bariatric surgery.","volume":"19","author":"Segal","year":"2009","journal-title":"Obes Surg"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11695-010-0163-6","article-title":"The impact of bariatric surgery on comorbidities and medication use among obese patients.","volume":"20","author":"Cremieux","year":"2010","journal-title":"Obes Surg"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2010.06.016","article-title":"Risk of suicide after long-term follow-up from bariatric surgery.","volume":"123","author":"Tindle","year":"2010","journal-title":"Am J Med"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery.","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"R18-5-20210128","first-page":"CD003641","article-title":"Surgery for morbid obesity.","volume":"4","author":"Colquitt","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00002727-200507000-00002","article-title":"A brief overview of bariatric surgical procedures currently being used to treat the obese patient.","volume":"28","author":"Hydock","year":"2005","journal-title":"Crit Care Nurs Q"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","article-title":"Medication and nutrient administration considerations after bariatric surgery.","volume":"63","author":"Miller","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00075197-200409000-00010","article-title":"Nutrient deficiencies secondary to bariatric surgery.","volume":"7","author":"Alvarez-Leite","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0012.2007.00783.x","article-title":"Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study.","volume":"22","author":"Rogers","year":"2008","journal-title":"Clin Transplant"},{"key":"R23-5-20210128","first-page":"414","article-title":"Gastric bypass in morbidly obese kidney transplant recipients.","volume":"10","author":"Marterre","year":"1996","journal-title":"Clin Transplant"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2009.00614.x","article-title":"A systematic review of drug absorption following bariatric surgery and its theoretical implications.","volume":"11","author":"Padwal","year":"2010","journal-title":"Obes Rev"},{"key":"R25-5-20210128","first-page":"1552","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/clpt.2009.82","article-title":"Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients.","volume":"86","author":"Skottheim","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1381\/096089206778026316","article-title":"Systematic review of medium-term weight loss after bariatric operations.","volume":"16","author":"OBrien","year":"2006","journal-title":"Obes Surg"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-155-5-201109060-00005","article-title":"Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial.","volume":"155","author":"Sovik","year":"2011","journal-title":"Ann Intern Med"},{"key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.soard.2010.12.003","article-title":"Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort.","volume":"8","author":"Roerig","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","article-title":"Duloxetine: clinical pharmacokinetics and drug interactions.","volume":"50","author":"Knadler","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1592\/phco.30.2.217","article-title":"Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature.","volume":"30","author":"Wills","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3122\/jabfm.2007.03.060177","article-title":"Malabsorption of oral antibiotics in pregnancy after gastric bypass surgery.","volume":"20","author":"Magee","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1592\/phco.28.12.1537","article-title":"Warfarin resistance after total gastrectomy and Roux-en-Y esophagojejunostomy.","volume":"28","author":"Sobieraj","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/clpt.2010.32","article-title":"Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch.","volume":"87","author":"Skottheim","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.soard.2007.12.002","article-title":"Relationship of body mass index with demographic and clinical characteristics in the Longitudinal Assessment of Bariatric Surgery (LABS).","volume":"4","author":"LABS Writing Group for the LABS Consortium, Belle","year":"2008","journal-title":"Surg Obes Relat Dis"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182905ffb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:36Z","timestamp":1620957696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201308000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182905ffb","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}